COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
about
COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
COAST (Cisplatin ototoxicity a ...... isplatin induced hearing-loss.
@en
COAST (Cisplatin ototoxicity a ...... isplatin induced hearing-loss.
@nl
type
label
COAST (Cisplatin ototoxicity a ...... isplatin induced hearing-loss.
@en
COAST (Cisplatin ototoxicity a ...... isplatin induced hearing-loss.
@nl
prefLabel
COAST (Cisplatin ototoxicity a ...... isplatin induced hearing-loss.
@en
COAST (Cisplatin ototoxicity a ...... isplatin induced hearing-loss.
@nl
P2093
P2860
P50
P1154
2-s2.0-85033375845
P1476
COAST (Cisplatin ototoxicity a ...... isplatin induced hearing-loss.
@en
P2093
Andrew Hartley
Angeliki Galanopoulou
Ben Lineton
Carolynn Lamb
Chris Nutting
Christian Ottensmeier
Gareth Thomas
Ian Ratcliffe
Joe Davies
P2860
P356
10.1016/J.EJCA.2017.09.033
P5530
P577
2017-11-09T00:00:00Z
P6179
1092632154